000 01391 a2200361 4500
005 20250513190624.0
264 0 _c19991229
008 199912s 0 0 eng d
022 _a0006-3223
024 7 _a10.1016/s0006-3223(99)00070-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKinkead, B
245 0 0 _aDoes neurotensin mediate the effects of antipsychotic drugs?
_h[electronic resource]
260 _bBiological psychiatry
_cAug 1999
300 _a340-51 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBasal Ganglia Diseases
_xchemically induced
650 0 4 _aCorpus Striatum
_xdrug effects
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aNeurotensin
_xmetabolism
650 0 4 _aNucleus Accumbens
_xdrug effects
650 0 4 _aRNA, Messenger
_xdrug effects
650 0 4 _aReceptors, Neurotensin
_xdrug effects
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aBinder, E B
700 1 _aNemeroff, C B
773 0 _tBiological psychiatry
_gvol. 46
_gno. 3
_gp. 340-51
856 4 0 _uhttps://doi.org/10.1016/s0006-3223(99)00070-0
_zAvailable from publisher's website
999 _c10392969
_d10392969